Risk-adapted strategy or universal multimodal approach for PONV prophylaxis?


Journal

Best practice & research. Clinical anaesthesiology
ISSN: 1878-1608
Titre abrégé: Best Pract Res Clin Anaesthesiol
Pays: Netherlands
ID NLM: 101121446

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 12 03 2020
revised: 23 04 2020
accepted: 05 05 2020
entrez: 8 12 2020
pubmed: 9 12 2020
medline: 2 6 2021
Statut: ppublish

Résumé

The issue of postoperative nausea and vomiting (PONV) remains important in surgical practice, contributing to patient distress, slower recovery, and increased use of healthcare resources. Many surgical patients report it to be a worse problem than pain. Numerous findings of research indicate that PONV significantly affects patients' well-being and is among the important determinants of patient satisfaction with perioperative care. Numerous investigations have confirmed the efficacy of combining pharmacological interventions indicating that PONV is a clinical complication that is in principle avoidable. Nonetheless, PONV continues to be bothersome for too many patients. Thus, perhaps the biggest challenge across the field is to achieve a uniformly high standard of PONV management using the currently available resources. Although a risk-adapted approach has been advocated in the past, the current trend incorporated in clinical guidelines support a more liberal approach of multimodal antiemetic prevention. The current article emphasizes pros and cons of the various approaches to PONV prophylaxis and depicts most promising strategies to achieve a "PONV-free hospital."

Identifiants

pubmed: 33288122
pii: S1521-6896(20)30036-7
doi: 10.1016/j.bpa.2020.05.003
pii:
doi:

Substances chimiques

Antiemetics 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

721-734

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest PK acted as clinical investigator in clinical trials on PONV and received patient-related fees to conduct the studies. He is also the coauthor of the cited consensus statements on PONV published by the Society of Ambulatory Anesthesia (SAMBA) and American Society for Enhanced Recovery (ASER).

Auteurs

Peter Kranke (P)

Department of Anaesthesia and Critical Care, University Hospitals of Wuerzburg, Germany. Electronic address: kranke_p@ukw.de.

Patrick Meybohm (P)

Department of Anaesthesia and Critical Care, University Hospitals of Wuerzburg, Germany.

Pierre Diemunsch (P)

Service d'Anesthésie - Réanimation Chirurgicale, CHU de Hautepierre, Strasbourg, France.

Leopold H J Eberhart (LHJ)

Department of Anaesthesiology and Intensive Care, Philipps-University Marburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH